Norma Biln

Affiliations

Augurex Life Sciences Corp., Vancouver, British Columbia, Canada.

ORCID: 0000-0003-2164-8044

Publications (3)

Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.

Scandinavian journal of rheumatology

Avec: M B Raft , M L Hetland , C H Brahe , K Hørslev-Petersen , L Midtbøll Ørnbjerg , P Junker , N Biln , K Stengaard-Pedersen , M Østergaard

Patient Perspectives on a Digital Mobile Health Application for RA.

Open access rheumatology : research and reviews

Avec: Simran Chahal , Norma Biln , Bruce Clarke

Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages.

Arthritis research & therapy

Avec: Gulzhan Trimova , Kaoru Yamagata , Shigeru Iwata , Shintaro Hirata , Tong Zhang , Fumi Uemura , Minoru Satoh , Norma Biln , Shingo Nakayamada , Walter P Maksymowych , Yoshiya Tanaka

Réseau de co-auteurs

M B Raft 1 collaboration

M L Hetland 1 collaboration

C H Brahe 1 collaboration

K Hørslev-Petersen 1 collaboration

L Midtbøll Ørnbjerg 1 collaboration

P Junker 1 collaboration

N Biln 1 collaboration

K Stengaard-Pedersen 1 collaboration

M Østergaard 1 collaboration

Simran Chahal 1 collaboration

Bruce Clarke 1 collaboration

Gulzhan Trimova 1 collaboration

Kaoru Yamagata 1 collaboration

Shigeru Iwata 1 collaboration

Shintaro Hirata 1 collaboration

Tong Zhang 1 collaboration

Fumi Uemura 1 collaboration

Minoru Satoh 1 collaboration

Shingo Nakayamada 1 collaboration

Walter P Maksymowych 1 collaboration

Yoshiya Tanaka 1 collaboration